Stocks · Health care · Biological Products, (No Diagnostic Substances)

MiNK Therapeutics, Inc.

INKT Clue Score16

United States Fiscal year ends December CIK 0001840229 Results filed 13 Aug 2026

Add to watchlist

By person

11 insiders · 27 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Agenus Inc entity

10% owner

$17.49M (14)

—

+$17.49M

21,772,863

—

$229.92M

−28.1%

Jennifer Buell

Chief Executive Officer

—

$73.27K (1)

−$73.27K

74,195

1.45%

$783.50K

—

Barbara Ryan

Director

—

$46.62K (8)

−$46.62K

23,591

0.4623%

$249.12K

—

Ulf Wiinberg

Director

$27.65K (2)

—

+$27.65K

51,759

1.01%

$546.58K

—

Garo H Armen

Director

$94.85K (1)

$0.00

1,866,400

36.57%

$19.71M

0.0%

Brian Corvese

Director

—

54,770

1.07%

$578.37K

—

John Baldoni

Director

—

41,193

0.8072%

$435.00K

—

Dijk Marcus Antonius van

Chief Scientific Officer

—

27,363

0.5362%

$288.95K

—

Peter Behner

Director

—

24,404

0.4782%

$257.71K

—

Robert Peter Kadlec

Director

—

19,126

0.3748%

$201.97K

+1,457%

John Bradley Holcomb

Director

—

4,691

0.0919%

$49.54K

—

MiNK Therapeutics, Inc.

What the insiders did Net buying

By person